Influence of flow-controlled ventilation (FCV) on regional ventilation in obese patients.

Influence of flow-controlled ventilation (FCV) on regional ventilation in obese patients. - FCV and obesity

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00014925

Enrollment

Registered

2018-07-12

Start date

2018-07-30

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E66.0

Interventions

Group 1: There is one group of patients. This group will be split (randomly) into two different intervention groups. Within these two groups, the different ventilation settings will be applied in a cr

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: = 18 years of age, elective surgery, ASA (American Society of Anesthesiologists) status 1-3, obesity with BMI = 30 kg/m², written consent of the patient.

Exclusion criteria

Exclusion criteria: COPD (stadium COPD = Gold III, clinical presentation, other known lung diseases, pacemaker, implantable cardioverter-defibrillator or other active electrical implants, heart defect, urgent surgery.

Design outcomes

Primary

Measure	Time frame
Regional ventilation (end-expiratory lung volume), measured via electrical impedance tomography	—

Secondary

Measure	Time frame
Volumes, pressures and flows of ventilation (plateau pressure, mean tracheal airway pressure, respiratory system compliance, haemodynamic variables: heart rate and mean arterial pressure), ins- and expiratory concentration of oxygen and carbon dioxide, mean lung volume (EIT).	—

Countries

Germany

Contacts

Public ContactStefan Schumann

Klinik für Anästhesiologie und Intensivmedizin Universitätsklinikum Freiburg

stefan.schumann@uniklinik-freiburg.de076127023290

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 28, 2026